Skip to main content

Regulation

By Jessica Hagen | 12:57 pm | July 03, 2023
The FDA-cleared and CE-marked image analysis software helps providers diagnose and monitor patients with neurological conditions.
By Jessica Hagen | 02:57 pm | June 20, 2023
BabySat, available via prescription, alerts parents when their baby's heart rate or blood oxygen saturation falls out of a prescribed range.
By Jessica Hagen | 01:26 pm | June 14, 2023
The company will first use the patent to combine the Apple Watch with Apple's new augmented reality headset Apple Vision Pro for closed loop AI-enabled treatment.
By Jessica Hagen | 01:53 pm | June 13, 2023
The FDA clearance comes just three months after the company received EU MDR Class IIb certification for its configurable disease management platform.
By Jessica Hagen | 01:38 pm | June 09, 2023
Alberta Spreafico, managing director of digital health and innovation at Healthware, shares how the report can guide companies' go-to-market strategies for entering the European market.
By Jessica Hagen | 01:00 pm | June 08, 2023
The company was also the first to receive emergency use authorization for its home COVID-19 test in 2021.
By Jessica Hagen | 12:35 pm | May 31, 2023
The company's Precision DL speeds up screening time, enhances the image quality of PET/CT scans and improves small lesion detection.
By Jessica Hagen | 12:47 pm | May 25, 2023
The company's iPredict System allows providers to detect age-related macular degeneration in the clinical setting. 
By Jessica Hagen | 10:59 am | May 12, 2023
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the market for digital therapeutics after Pear Therapeutics declared bankruptcy.
By Jessica Hagen | 11:42 am | May 11, 2023
The company's ANNE One platform allows for wireless monitoring of neonates and infants' skin and body temperature, heart and respiratory rates, and more.